Aflac Incorporated (NYSE:AFL) Shares Sold by Atomi Financial Group Inc.

Atomi Financial Group Inc. reduced its holdings in Aflac Incorporated (NYSE:AFL) by 2.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,238 shares of the financial services provider’s stock after selling 251 shares during the quarter. Atomi Financial Group Inc.’s holdings in Aflac were worth $1,266,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in AFL. Darwin Wealth Management LLC bought a new position in shares of Aflac in the third quarter worth $34,000. Raelipskie Partnership acquired a new stake in Aflac in the third quarter worth about $38,000. Covestor Ltd lifted its holdings in Aflac by 41.8% in the third quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock worth $41,000 after purchasing an additional 107 shares during the period. Kennebec Savings Bank bought a new position in Aflac in the 3rd quarter valued at about $45,000. Finally, Catalyst Capital Advisors LLC acquired a new position in Aflac during the 3rd quarter valued at about $51,000. Institutional investors own 67.44% of the company’s stock.

Insider Buying and Selling

In related news, EVP Audrey B. Tillman sold 24,744 shares of Aflac stock in a transaction on Friday, December 27th. The shares were sold at an average price of $103.40, for a total value of $2,558,529.60. Following the completion of the sale, the executive vice president now owns 222,618 shares of the company’s stock, valued at approximately $23,018,701.20. The trade was a 10.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.80% of the stock is currently owned by corporate insiders.

Aflac Stock Down 0.1 %

Aflac stock opened at $106.36 on Wednesday. Aflac Incorporated has a twelve month low of $75.07 and a twelve month high of $115.50. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.08 and a current ratio of 0.08. The firm has a market cap of $59.09 billion, a PE ratio of 16.02, a P/E/G ratio of 2.20 and a beta of 1.00. The firm’s 50 day moving average price is $106.33 and its two-hundred day moving average price is $105.59.

Aflac (NYSE:AFL) last posted its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share for the quarter, topping analysts’ consensus estimates of $1.69 by $0.47. Aflac had a net margin of 22.02% and a return on equity of 16.34%. The business had revenue of $2.95 billion for the quarter, compared to the consensus estimate of $4.30 billion. During the same period in the prior year, the business posted $1.84 earnings per share. Aflac’s revenue for the quarter was down 40.4% compared to the same quarter last year. On average, research analysts predict that Aflac Incorporated will post 7.26 EPS for the current fiscal year.

Aflac Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Stockholders of record on Wednesday, February 19th will be issued a dividend of $0.58 per share. This represents a $2.32 annualized dividend and a dividend yield of 2.18%. This is a positive change from Aflac’s previous quarterly dividend of $0.50. The ex-dividend date of this dividend is Wednesday, February 19th. Aflac’s payout ratio is currently 34.94%.

Analysts Set New Price Targets

A number of research firms have weighed in on AFL. Truist Financial upped their target price on Aflac from $100.00 to $105.00 and gave the stock a “hold” rating in a research report on Friday, November 1st. Evercore ISI cut their price objective on Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a report on Wednesday, December 4th. Bank of America lifted their target price on Aflac from $115.00 to $124.00 and gave the stock a “buy” rating in a report on Thursday, October 10th. JPMorgan Chase & Co. upped their price target on shares of Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a report on Tuesday, January 7th. Finally, Keefe, Bruyette & Woods reduced their price objective on shares of Aflac from $108.00 to $107.00 and set a “market perform” rating for the company in a research report on Friday, January 10th. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $102.07.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.